Integrated Core Strategies (US) LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 4:00 pm Sale |
2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Integrated Core Strategies (US) LLC | 1,994,503 3.500% |
-954,373 (-32.36%) |
Filing |
| 2024-11-01 4:05 pm Purchase |
2024-10-28 | 13G | Astria Therapeutics, Inc. ATXS |
Integrated Core Strategies (US) LLC | 2,948,876 5.200% |
2,948,876 (New Position) |
Filing |